Transformation from adenocarcinoma to squamous cell lung carcinoma with MET amplification after lorlatinib resistance: A case report

To date, several studies have described the mechanism of resistance to first‐ or second‐generation anaplastic lymphoma kinase (ALK) inhibitors. Secondary ALK mutations, ALK gene amplification, and other bypass signal activations (i.e., KRAS mutation, EGFR mutation, amplification of KIT, and increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Shoko, Shukuya, Takehito, Hayashi, Takuo, Suzuki, Mario, Kondo, Akihide, Arai, Yuta, Takeshige, Tomohito, Ninomiya, Hironori, Takahashi, Kazuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919122/
https://www.ncbi.nlm.nih.gov/pubmed/33475256
http://dx.doi.org/10.1111/1759-7714.13829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919122/
https://www.ncbi.nlm.nih.gov/pubmed/33475256
http://dx.doi.org/10.1111/1759-7714.13829

Ejemplares similares